Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 8, 2021

View Archived Issues

AstraZeneca patents SLC12A5 activators

Minghui Pharmaceutical scientists synthesize new JAK inhibitors

Evotec presents ISR pathway modulators

MCT4 is a prognostic marker in anaplastic thyroid cancer

Merck KGaA and Ryvu Therapeutics divulge new ACSS2 inhibitors

Sichuan Haisco Pharmaceutical describes new JAK inhibitors

SG-3-00802 shows encouraging preclinical activity in combination with anti-PD-1 therapy

HC-070 attenuates stress-related excessive sensitivity to aversion and apathy for reward in mice

Stealth's SBT-272 shows promise in murine model of ALS

Development of cell-penetrating asymmetric siRNAs for treating androgenetic alopecia

NK-92 with truncated PD-1 shows enhanced therapeutic effects

Dapiglutide attenuates intestinal insufficiency in vivo

Aileron Therapeutics' ALRN-6924 shows preclinical activity against acute radiation injury

Rare APOE variant gives insight into Alzheimer's pathogenesis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...